News & Press

CordenPharma COVID-19 Customer Letter

April 20, 2021
COVID-19 > Read CEO Dr. Micheal Quirmbach's Customer Letter Response to COVID-19.

CordenPharma’s Weekly Update to COVID-19 (Novel Coronavirus)

Please Read CEO & President Dr. Michael Quirmbach’s Letter to Customers

Watch our COVID-19 Video Updates and Success Stories Here

Please click here to inform us of any urgent questions or concerns regarding COVID-19

Dear Valued Customer,

After serious consideration, I have chosen to relax our strict no-visitor policy at all CordenPharma facilities. Although we continue to see rising numbers of COVID-19 cases in some global locations, in others we see an encouraging reduction, and with vaccine rollout picking up pace, I hope we are entering more of a control & management phase of the pandemic. Because of this geographic variance and the rapidly changing situation with respect to government controls and policies in place, it no longer makes sense for the organization to have a blanket policy regarding audits & customer visits.

Therefore beginning April 5, 2021, I have instructed all CordenPharma facilities Managing Directors to assess visit requests on a case-by-case basis, taking into consideration local and national government directives, business criticality of the request, and geographic origin of the requesting company or visiting personnel.

Although we have chosen to relax our visitation rules, we will obviously monitor the situation closely. Please be aware that changes to a visit access decision may occur on short notice if deemed necessary by local situations that suddenly arise. Also of note, we will limit the number of visitors from all companies to one representative, and will require that visitor to provide a negative PCR test result taken within 48 hours prior to arrival.

Thanks to the consistent efforts and hard work of all CordenPharma employees at the site level, we have fortunately experienced minimal disruptions to our regular operations. We intend to continue this vigilance and success in the remainder of 2021.

Rest assured that all CordenPharma employees, from the Executive Leadership Team and Facility Managing Directors to the Operators and Marketing & Sales Team, are aligned and committed to mitigating any impact on delivering your critical, often lifesaving, medications. We are doing everything possible on our end to support your patients through this crisis.

We appreciate your patience as we react to this global issue, and thank you for your ongoing support in returning to “business as usual” as quickly as possible. Feel free to reach out to your Key Account Managers or fill out this form with any questions or concerns.

I wish you and your families stay safe & healthy, as we continue to work together as a collective community to support business continuity and each other.

Best Regards,

Dr. Michael Quirmbach
Chief Executive Officer & President